Cubist Announces EMA Acceptance of Tedizolid Marketing Authorization Application for Review

[at noodls] – LEXINGTON, Mass.–(BUSINESS WIRE)– Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that the European Medicines Agency (EMA) has accepted for review the Company’s Marketing Authorization Application … more

View todays social media effects on CBST

View the latest stocks trending across Twitter. Click to view dashboard

See who Cubist is hiring next, click here to view